Capital Advisors Inc Amgen Inc Transaction History

Capital Advisors Inc

$4.86 Billion
Q3 2024

A detailed history of Capital Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Capital Advisors Inc holds 2,126 shares of AMGN stock, worth $559,945. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,126

Previous 2,565 17.12%

Holding current value

$559,945

Previous $801,000 14.48%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $135,817 - $148,109	-439 Reduced 17.12%	2,126 $685,000
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $17,604 - $21,393	67 Added 2.68%	2,565 $801,000
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.08%	2,498 $710,000
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $112,508 - $126,922	-440 Reduced 14.99%	2,496 $718,000
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $176,450 - $219,068	-807 Reduced 21.56%	2,936 $789,000
Q2 2023 Jul 18, 2023	BUY	$214.27 - $253.37 $144,417 - $170,771	674 Added 21.96%	3,743 $831,000
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $44,932 - $54,764	-199 Reduced 6.09%	3,069 $741,000
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $354,767 - $450,774	-1,549 Reduced 32.16%	3,268 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $13,467 - $15,189	60 Added 1.26%	4,817 $1.09 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $17,072 - $18,998	74 Added 1.58%	4,757 $1.16 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $114,458 - $126,621	522 Added 12.55%	4,683 $1.13 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $596 - $682	-3 Reduced 0.07%	4,161 $936,000
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $444,917 - $521,275	2,096 Added 101.35%	4,164 $885,000
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $4,671 - $5,182	-20 Reduced 0.96%	2,068 $504,000
Q1 2021 May 25, 2021	BUY	$221.91 - $258.6 $215,252 - $250,842	970 Added 86.76%	2,088 $519,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $44,357 - $52,822	205 Added 22.45%	1,118 $257,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $214,235 - $238,247	913 New	913 $232,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $291,019 - $328,042	-1,609 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $35,680 - $41,650	200 Added 14.19%	1,609 $313,000
Q2 2018 Aug 06, 2018	SELL	$166.05 - $186.51 $8,302 - $9,325	-50 Reduced 3.43%	1,409 $0
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $2,202 - $2,574	-13 Reduced 0.88%	1,459 $0
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $9,452 - $10,561	56 Added 3.95%	1,472 $256,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $58,551 - $66,850	-350 Reduced 19.82%	1,416 $264,000
Q2 2017 Aug 09, 2017	BUY	N/A	1,766	1,766 $304,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.

Account

Capital Advisors Inc Amgen Inc Transaction History